Francesca Blasco

Singapore, 138670, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

Journal: Antimicrobial agents and chemotherapy

Published: April 13, 2020

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

Journal: Science translational medicine

Published: February 28, 2020

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

Journal: Nature

Published: November 27, 2016

Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format.

Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 22, 2016

Artificial Neural Network Analysis of Pharmacokinetic and Toxicity Properties of Lead Molecules for Dengue Fever, Tuberculosis and Malaria.

Artificial Neural Network Analysis of Pharmacokinetic and Toxicity Properties of Lead Molecules for Dengue Fever, Tuberculosis and Malaria.

Journal: Current computer-aided drug design

Published: July 07, 2015

Discovery of Dengue Virus NS4B Inhibitors.

Discovery of Dengue Virus NS4B Inhibitors.

Journal: Journal of virology

Published: May 29, 2015

Direct inhibitors of InhA are active against Mycobacterium tuberculosis.

Direct inhibitors of InhA are active against Mycobacterium tuberculosis.

Journal: Science translational medicine

Published: January 09, 2015

Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors.

Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors.

Journal: ACS medicinal chemistry letters

Published: December 16, 2014

Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.

Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.

Journal: Antimicrobial agents and chemotherapy

Published: December 10, 2014

Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580.

Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580.

Journal: Antiviral research

Published: June 19, 2014

Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research.

Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research.

Journal: Frontiers in pharmacology

Published: May 02, 2014

Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis.

Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis.

Journal: PloS one

Published: April 08, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026